{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T08:41:07Z","timestamp":1793263267608,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.ijrobp.2023.06.246","type":"journal-article","created":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T02:07:59Z","timestamp":1688782079000},"page":"1222-1231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Expanded HILUS Trial: A Pooled Analysis of Risk Factors for Toxicity From Stereotactic Body Radiation Therapy of Central and Ultracentral Lung Tumors"],"prefix":"10.1016","volume":"117","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6634-4672","authenticated-orcid":false,"given":"Sara","family":"Lindberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitali","family":"Grozman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Karlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Onjukka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Lindb\u00e4ck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karam Al","family":"Jirf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingmar","family":"Lax","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Wers\u00e4ll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gitte Fredberg","family":"Persson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjana","family":"Josipovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azza Ahmed","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ditte Sloth","family":"M\u00f8ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lone","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne Marquard","family":"Knap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Nyman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ninni","family":"Drugge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Bergstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rgen","family":"Olofsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lotte Victoria","family":"Rogg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca Knoph","family":"Hagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sofie","family":"Fr\u00f8land","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Ramberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Kristiansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan Starup","family":"Jeppesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tine Bj\u00f8rn","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britta","family":"L\u00f6d\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Olov","family":"Rosenbrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silke","family":"Engelholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Haraldsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Billiet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Lewensohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Lindberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2023.06.246_bib0001","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1080\/09553002.2019.1552375","article-title":"Is stereotactic body radiotherapy for ultra-central lung tumor a feasible option? A systemic review and meta-analysis","volume":"95","author":"Rim","year":"2019","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.ijrobp.2023.06.246_bib0002","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.jtho.2019.04.018","article-title":"Safety and effectiveness of stereotactic ablative radiotherapy for ultra-central lung lesions: A systematic review","volume":"14","author":"Chen","year":"2019","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ijrobp.2023.06.246_bib0003","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/jamaoncol.2019.0205","article-title":"Analysis of toxic effects with antiangiogenic agents plus stereotactic body radiation in ultracentral lung tumors","volume":"5","author":"Wang","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ijrobp.2023.06.246_bib0004","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1200\/JCO.2006.07.5937","article-title":"Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer","volume":"24","author":"Timmerman","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2023.06.246_bib0005","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jtho.2016.03.008","article-title":"Outcomes of hypofractionated high-dose radiotherapy in poor-risk patients with \"ultracentral\" non-small cell lung cancer","volume":"11","author":"Tekatli","year":"2016","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ijrobp.2023.06.246_bib0006","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.ijrobp.2017.11.022","article-title":"normal tissue complication probability modeling of pulmonary toxicity after stereotactic and hypofractionated radiation therapy for central lung tumors","volume":"100","author":"Tekatli","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.06.246_bib0007","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1080\/0284186X.2021.1942545","article-title":"Ultra-central lung tumors: safety and efficacy of protracted stereotactic body radiotherapy","volume":"60","author":"Lodeweges","year":"2021","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2023.06.246_bib0008","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.jtho.2021.03.019","article-title":"The HILUS-trial - A prospective nordic multicenter phase 2 study of ultracentral lung tumors treated with stereotactic body radiotherapy","volume":"16","author":"Lindberg","year":"2021","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ijrobp.2023.06.246_bib0009","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1016\/j.prro.2015.09.012","article-title":"Fatal complications after stereotactic body radiation therapy for central lung tumors abutting the proximal bronchial tree","volume":"6","author":"Haseltine","year":"2016","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2023.06.246_bib0010","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s13014-016-0732-5","article-title":"SBRT for centrally localized NSCLC: What is too central?","volume":"11","author":"Roesch","year":"2016","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2023.06.246_bib0011","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1080\/0284186X.2021.1914345","article-title":"Local control after stereotactic body radiotherapy of centrally located lung tumours","volume":"60","author":"Khalil","year":"2021","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2023.06.246_bib0012","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.radonc.2013.01.004","article-title":"Outcomes of stereotactic ablative radiotherapy for central lung tumours: A systematic review","volume":"106","author":"Senthi","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2023.06.246_bib0013","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.lungcan.2015.04.014","article-title":"Stereotactic ablative radiotherapy (SABR) for treatment of central and ultra-central lung tumors","volume":"89","author":"Chaudhuri","year":"2015","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ijrobp.2023.06.246_bib0014","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.radonc.2018.07.001","article-title":"The safety and effectiveness of stereotactic body radiotherapy for central versus ultracentral lung tumors","volume":"129","author":"Chang","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2023.06.246_bib0015","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.adro.2019.01.002","article-title":"Long-term clinical outcomes and safety profile of SBRT for centrally located NSCLC","volume":"4","author":"Arnett","year":"2019","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2023.06.246_bib0016","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1097\/JTO.0b013e31822e71d8","article-title":"Outcomes of stereotactic ablative radiotherapy for centrally located early-stage lung cancer","volume":"6","author":"Haasbeek","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ijrobp.2023.06.246_bib0017","doi-asserted-by":"crossref","first-page":"e803","DOI":"10.1016\/j.cllc.2018.06.001","article-title":"Ultracentral tumors treated with stereotactic body radiotherapy: Single-institution experience","volume":"19","author":"Raman","year":"2018","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.ijrobp.2023.06.246_bib0018","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/JTO.0000000000000453","article-title":"Stereotactic ablative radiotherapy for centrally located early stage non-small-cell lung cancer: What we have learned","volume":"10","author":"Chang","year":"2015","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ijrobp.2023.06.246_bib0019","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1200\/JCO.18.00622","article-title":"Safety and efficacy of a five-fraction stereotactic body radiotherapy schedule for centrally located non-small-cell lung cancer: NRG Oncology\/RTOG 0813 trial","volume":"37","author":"Bezjak","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2023.06.246_bib0020","doi-asserted-by":"crossref","first-page":"e529","DOI":"10.1016\/j.cllc.2018.04.001","article-title":"SUNSET: Stereotactic radiation for ultracentral non-small-cell lung cancer-a safety and efficacy trial","volume":"19","author":"Giuliani","year":"2018","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.ijrobp.2023.06.246_bib0021","doi-asserted-by":"crossref","first-page":"981","DOI":"10.3390\/cancers7020820","article-title":"Complications from stereotactic body radiotherapy for lung cancer","volume":"7","author":"Kang","year":"2015","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijrobp.2023.06.246_bib0022","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ijrobp.2018.08.040","article-title":"Subgroup survival analysis in stage I-II NSCLC patients with a central tumor partly treated with risk-adapted SBRT","volume":"103","author":"Stam","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.06.246_bib0023","first-page":"41","article-title":"Medical consequences of radiation exposure of the bronchi: What can we learn from high-dose precision radiation therapy?","author":"Lindberg","year":"2021","journal-title":"J Radiol Prot"},{"key":"10.1016\/j.ijrobp.2023.06.246_bib0024","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.radonc.2021.03.001","article-title":"Ablative radiotherapy for ultracentral lung cancers: Dosimetric, geometric, and volumetric predictors of outcomes and toxicity","volume":"158","author":"Breen","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2023.06.246_bib0025","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.semradonc.2015.11.002","article-title":"Dose and volume of the irradiated main bronchi and related side effects in the treatment of central lung tumors with stereotactic radiotherapy","volume":"26","author":"Duijm","year":"2016","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2023.06.246_bib0026","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1001\/jama.2010.261","article-title":"Stereotactic body radiation therapy for inoperable early stage lung cancer","volume":"303","author":"Timmerman","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.ijrobp.2023.06.246_bib0027","unstructured":"National Cancer Insitute. Common Terminology Criteria for Adverse Events (CTCAE). Available at:https:\/\/evs.nci.nih.gov\/ftp1\/CTCAE\/CTCAE_4.03\/Archive\/CTCAE_4.0_2009-05-29_QuickReference_8.5x11.pdf. Accessed August 11, 2022."},{"key":"10.1016\/j.ijrobp.2023.06.246_bib0028","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejca.2016.03.081","article-title":"RECIST 1.1-Update and clarification: From the RECIST committee","volume":"62","author":"Schwartz","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2023.06.246_bib0029","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1200\/JCO.2008.21.5681","article-title":"Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy","volume":"27","author":"Baumann","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2023.06.246_bib0030","unstructured":"R Project for Statistical Computing. Available at: https:\/\/www.R-project.org\/. Accessed October 2, 2022."},{"key":"10.1016\/j.ijrobp.2023.06.246_bib0031","first-page":"4498","article-title":"Stereotactic body radiotherapy for centrally-located lung tumors with 56 Gy in seven fractions: A retrospective study","volume":"16","author":"Aoki","year":"2018","journal-title":"Oncol Lett"},{"key":"10.1016\/j.ijrobp.2023.06.246_bib0032","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1097\/JTO.0000000000000260","article-title":"Toxicities of organs at risk in the mediastinal and hilar regions following stereotactic body radiotherapy for centrally located lung tumors","volume":"9","author":"Nishimura","year":"2014","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ijrobp.2023.06.246_bib0033","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.lungcan.2020.07.009","article-title":"Analysis of pneumonitis and esophageal injury after stereotactic body radiation therapy for ultra-central lung tumors","volume":"147","author":"Wang","year":"2020","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ijrobp.2023.06.246_bib0034","doi-asserted-by":"crossref","first-page":"e196","DOI":"10.1016\/j.prro.2018.11.005","article-title":"Tumor control and toxicity after SBRT for ultracentral, central, and paramediastinal lung tumors","volume":"9","author":"Nguyen","year":"2019","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2023.06.246_bib0035","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1111\/cas.14185","article-title":"Risk-adapted stereotactic body radiation therapy for central and ultra-central early-stage inoperable non-small cell lung cancer","volume":"110","author":"Meng","year":"2019","journal-title":"Cancer Sci"},{"key":"10.1016\/j.ijrobp.2023.06.246_bib0036","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1756-8722-3-39","article-title":"CyberKnife for hilar lung tumors: report of clinical response and toxicity","volume":"3","author":"Unger","year":"2010","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.ijrobp.2023.06.246_bib0037","series-title":"Anatomy, Thorax, Bronchial","author":"Amador","year":"2022"},{"key":"10.1016\/j.ijrobp.2023.06.246_bib0038","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.thorsurg.2018.02.003","article-title":"Fundamental and practical aspects of airway anatomy: From glottis to segmental bronchus","volume":"28","author":"Mehran","year":"2018","journal-title":"Thorac Surg Clin"},{"key":"10.1016\/j.ijrobp.2023.06.246_bib0039","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.thorsurg.2006.12.006","article-title":"Anatomy of the trachea, carina, and bronchi","volume":"17","author":"Minnich","year":"2007","journal-title":"Thorac Surg Clin"},{"key":"10.1016\/j.ijrobp.2023.06.246_bib0040","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.ijrobp.2013.06.2055","article-title":"Retrospective cohort study of bronchial doses and radiation-induced atelectasis after stereotactic body radiation therapy of lung tumors located close to the bronchial tree","volume":"87","author":"Karlsson","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.06.246_bib0041","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.5858\/arpa.2011-0521-OA","article-title":"Causes of death of patients with lung cancer","volume":"136","author":"Nichols","year":"2012","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.ijrobp.2023.06.246_bib0042","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/1097-0142(19800701)46:1<200::AID-CNCR2820460133>3.0.CO;2-V","article-title":"Hemorrhage from carcinoma of the lung","volume":"46","author":"Miller","year":"1980","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2023.06.246_bib0043","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/4518935","article-title":"Risk factors for fatal pulmonary hemorrhage following concurrent chemoradiotherapy in stage 3B\/C squamous-cell lung carcinoma patients","volume":"2018","author":"Topkan","year":"2018","journal-title":"J Oncol"},{"key":"10.1016\/j.ijrobp.2023.06.246_bib0044","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1471-2407-12-27","article-title":"Risk factors associated with fatal pulmonary hemorrhage in locally advanced non-small cell lung cancer treated with chemoradiotherapy","volume":"12","author":"Ito","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ijrobp.2023.06.246_bib0045","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.728519","article-title":"Lobar gross endobronchial disease predicts for overall survival and grade 5 pulmonary toxicity in medically inoperable early stage non-small cell lung cancer patients treated with stereotactic body radiation therapy","volume":"11","author":"Aghdam","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2023.06.246_bib0046","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.radonc.2022.04.005","article-title":"Thorough design and pre-trial quality assurance (QA) decrease dosimetric impact of delineation and dose planning variability in the STRICTLUNG and STARLUNG trials for stereotactic body radiotherapy (SBRT) of central and ultra-central lung tumours","volume":"171","author":"Hoffmann","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2023.06.246_bib0047","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1442-2050.2011.01295.x","article-title":"Esophageal tolerance to high-dose stereotactic ablative radiotherapy","volume":"25","author":"Abelson","year":"2012","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.ijrobp.2023.06.246_bib0048","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1097\/JTO.0b013e3181858eba","article-title":"Tracheo-esophageal fistula with bevacizumab after mediastinal radiation","volume":"3","author":"Goodgame","year":"2008","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ijrobp.2023.06.246_bib0049","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1111\/1759-7714.13105","article-title":"Outcomes and toxicity of stereotactic body radiation therapy for advanced stage ultra-central non-small cell lung cancer","volume":"10","author":"Cong","year":"2019","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.ijrobp.2023.06.246_bib0050","doi-asserted-by":"crossref","first-page":"409","DOI":"10.4236\/jct.2021.127036","article-title":"Impact of cardiac dose on overall survival in lung stereotactic body radiotherapy (SBRT) compared to conventionally fractionated radiotherapy for locally advanced non-small cell lung cancer (LA-NSCLC)","volume":"12","author":"Anderson","year":"2021","journal-title":"J Cancer Ther"},{"key":"10.1016\/j.ijrobp.2023.06.246_bib0051","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/cncr.20539","article-title":"Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: Clinical outcomes in 245 subjects in a Japanese multiinstitutional study","volume":"101","author":"Onishi","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2023.06.246_bib0052","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.21037\/jtd.2019.12.12","article-title":"A systematic review and meta-analysis of stereotactic body radiation therapy for colorectal pulmonary metastases","volume":"11","author":"Cao","year":"2019","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.ijrobp.2023.06.246_bib0053","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1097\/JTO.0b013e318219aac5","article-title":"Radiological changes after stereotactic radiotherapy for stage I lung cancer","volume":"6","author":"Dahele","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ijrobp.2023.06.246_bib0054","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1148\/rg.2018170155","article-title":"Stereotactic body radiation therapy for early-stage non-small cell lung cancer: A primer for radiologists","volume":"38","author":"Febbo","year":"2018","journal-title":"Radiographics"},{"key":"10.1016\/j.ijrobp.2023.06.246_bib0055","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.chest.2019.03.033","article-title":"Radiation-induced lung injury: Assessment and management","volume":"156","author":"Hanania","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.ijrobp.2023.06.246_bib0056","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1016\/j.jtho.2021.06.030","article-title":"The Nordic-HILUS trial: Ultracentral lung stereotactic ablative radiotherapy and a narrow therapeutic window","volume":"16","author":"Rosenberg","year":"2021","journal-title":"J Thorac Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301623044784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301623044784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T10:10:17Z","timestamp":1759745417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301623044784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":56,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S0360301623044784"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2023.06.246","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expanded HILUS Trial: A Pooled Analysis of Risk Factors for Toxicity From Stereotactic Body Radiation Therapy of Central and Ultracentral Lung Tumors","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2023.06.246","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}